Anti-alpha 1 Fetoprotein antibody [CPT-R19-48-7],Abcam,AB241324

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human

Application

ELISA

Platform ID

BAB574536028

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-alpha 1 Fetoprotein antibody [CPT-R19-48-7]
Cat. No.AB241324
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationELISA
ClonalityMonoclonal
Clone NumberCPT-R19-48-7
Concentration1.111 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 0.59% Sodium citrate, 0.03% EDTA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Binds copper, nickel, and fatty acids as well as, and bilirubin less well than, serum albumin. Only a small percentage (less than 2%) of the human AFP shows estrogen-binding properties. See full target information AFP

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.